MCLAUGHLIN KEVIN F 4
4 · Vericel Corp · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
Vericel (VCEL) Director Kevin McLaughlin Exercises Options, Sells Shares
What Happened
Kevin F. McLaughlin, a director of Vericel Corp (VCEL), exercised derivative securities for a total of 14,000 shares on May 13, 2026 and sold 7,000 of those shares the same day. The exercises included 3,500 shares at $2.63 ($9,205), 3,500 at $13.05 ($45,675) and two 3,500-share derivative events reported at $0.00. The two same‑day open‑market sales were 3,500 shares at $32.83 ($114,905) and 3,500 shares at $32.82 ($114,870), for total sale proceeds of $229,775. After exercise costs of $54,880, the net cash from the dispositions is roughly $174,895.
Key Details
- Transaction date: May 13, 2026 (Form 4 filed May 15, 2026); filing appears timely.
- Exercises (M): 3,500 @ $2.63 = $9,205; 3,500 @ $13.05 = $45,675; 3,500 @ $0.00; 3,500 @ $0.00 (total exercised = 14,000 shares).
- Sales (S): 3,500 @ $32.83 = $114,905; 3,500 @ $32.82 = $114,870 (total sold = 7,000 shares; proceeds = $229,775).
- Shares owned after transaction: Not specified in the filing.
- Footnotes: F1 — sales were automatic under a Rule 10b5‑1 trading plan adopted May 12, 2025. F2/F3 — the exercised options trace to grants from May 3, 2017 and May 2, 2018 that vested over time.
- Transaction codes: M = option/derivative exercise, S = sale.
Context
Because the exercises and sales occurred the same day and the sales were executed under a 10b5‑1 plan, this is effectively a cashless exercise/sale structure commonly used to cover exercise costs and tax obligations. Such routine plan‑based sales do not necessarily signal an insider’s view of the company’s prospects.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-05-13$2.63/sh+3,500$9,205→ 21,800 total - Sale
Common Stock
[F1]2026-05-13$32.83/sh−3,500$114,905→ 18,300 total - Exercise/Conversion
Common Stock
2026-05-13$13.05/sh+3,500$45,675→ 21,800 total - Sale
Common Stock
[F1]2026-05-13$32.82/sh−3,500$114,870→ 18,300 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-05-13+3,500→ 0 totalExercise: $2.63Exp: 2027-05-03→ Common Stock (3,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-05-13+3,500→ 14,000 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (3,500 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
- [F2]These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
- [F3]These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.